{
  "questions": [
    "What was the financial support provided for the research, authorship, and/or publication of this article, as disclosed by the authors?\"",
    "What are the typical pathophysiological changes associated with Alzheimer's disease, according to this article?",
    "What are the key guidelines recommended by the National Institute on Aging-Alzheimer's Association workgroups for diagnosing Alzheimer's disease and mild cognitive impairment?\"",
    "What were the recommendations for diagnosing Alzheimer's disease made by the National Institute on Aging-Alzheimer's Association workgroups in 2011?",
    "What are the primary recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease?",
    "What are the key findings reported in the World Alzheimer Report 2015 mentioned in this reference list?",
    "What is the current state of Alzheimer's disease treatment options, according to the article?",
    "Are microRNAs mentioned as potential biomarkers for Alzheimer's disease in this text?",
    "\"What type of funding did PMX provide for the study mentioned in the text?\"",
    "What are the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease?\"",
    "\"What is the purpose of providing ORCID iDs in this article?\"",
    "What is the current status of Alzheimer's disease treatment, according to this article, and what are the implications for future research?",
    "",
    "Who are the corresponding authors and what is their affiliation?",
    "Who designed and conceptualized the study, interpreted data, and critically revised the manuscript?",
    "What is the primary purpose of the provided Creative Commons licence?",
    "\"What is the earliest detectable pathological biomarker in Alzheimer's disease (AD) and how long before the onset of dementia can it develop?\"",
    "What are the research criteria proposed by Dubois et al. (2007) for diagnosing Alzheimer's disease?",
    "Is there a conflict of interest mentioned in this research article?",
    "Why are the research data and materials not available due to a confidentiality agreement required by the institutional review board?",
    "What are the diagnostic guidelines for mild cognitive impairment due to Alzheimer's disease recommended by the National Institute on Aging-Alzheimer's Association workgroups?",
    "What is the main purpose of the provided Creative Commons licence and what does it entail?",
    "",
    "What are the current diagnostic guidelines for Alzheimer's disease, as recommended by the National Institute on Aging-Alzheimer's Association workgroups?",
    "What is the estimated prevalence of dementia worldwide and how is it expected to change by 2040?",
    "What is the key finding from the comparative cohort study comparing prevalence of comorbidity in patients with young-onset Alzheimer disease versus late-onset?",
    "What are the current diagnostic guidelines for dementia due to Alzheimer's disease, according to the National Institute on Aging-Alzheimer's Association workgroups?",
    "What is the name of the research initiative mentioned in this text that focuses on Alzheimer's disease and neuroimaging?",
    "What is the purpose of the Creative Commons licence mentioned at the beginning of this text?",
    "What were the revised diagnostic criteria for Alzheimer's Disease proposed by Dubois and colleagues in 2007, and what was the key change introduced at that time?",
    "What are the potential benefits of intervening at the mild cognitive impairment stage due to Alzheimer's disease?",
    "What is the main distinguishing feature between Alzheimer's disease and mild cognitive impairment?",
    "Does the development of dementia pathology precede or coincide with cerebrovascular disease in Alzheimer's patients?",
    "What were the primary findings of the automated detection method developed by Perez-Valero et al. for distinguishing between MCI-non-AD patients, mild AD patients, and healthy controls?",
    "What study found that vascular dysfunction is the disregarded partner of Alzheimer's disease?",
    "Is the degree of tau pathology and cerebral blood flow in the lateral temporal and occipitoparietal regions more strongly associated with cognition in Early-onset Alzheimer's disease compared to Late-onset Alzheimer's disease?",
    "What is the Creative Commons license under which this article can be used?",
    "What were the key findings of the [(11)C]PIB-PET Centiloid values study regarding the relationships between antemortem and postmortem measures of Alzheimer's disease neuropathology?",
    "What are the primary biomarkers observed in the brains of patients with Alzheimer's disease mentioned in this study?",
    "What organizations provided financial support for the research described in this article?",
    "\"What is the article's primary focus on, given the listed authors' roles?\"",
    "What is the primary focus of each study cited in this list, and how do they contribute to our understanding of dementia or Alzheimer's disease?",
    "What are the two prodromal stages mentioned in the text that precede the overt neurological symptoms of neurodegenerative diseases?",
    "What is the main application of PET (Positron Emission Tomography) in Alzheimer's disease, according to Nordberg et al. (2010)?",
    "",
    "What is the purpose of the NIA-AA research framework mentioned in reference number 6?",
    "What is the estimated number of people affected by Alzheimer's disease worldwide and in the USA by 2060, according to the text?",
    "\"What was the source of the Creative Commons licence used in this article?\"",
    "What is the relationship between everyday cognition scales and cognitive function in the early stages of probable Alzheimer's disease, according to the study by Hsu et al. (2017)?",
    "What is the purpose of the A4 study, as mentioned in Sperling et al.'s 2014 publication?",
    "What was the goal of evaluating the Alzheimer's Disease Cooperative Study-Activities of Daily Living (ADCS-ADL) scale in both controls and individuals with Mild Cognitive Impairment (MCI) or Alzheimer's disease in Peru?",
    "",
    "What was the research approach that the authors advocated for future examination, according to this study?",
    "What is the significance of Subcortical Cognitive Decline (SCD) in relation to Alzheimer's disease and other dementias, according to this study?",
    "What type of license does this article use, according to its copyright statement?",
    "What are the references cited for the diagnosis of mild cognitive impairment due to Alzheimer's disease?",
    "What is the relationship between mild cognitive impairment and Alzheimer's disease, according to the study published in PLoS Computational Biology?",
    "What is the significance of medial temporal lobe atrophy in the context of Alzheimer's disease, as reported by Barkhof et al. in 2007?",
    "What percentage of people over the age of 80 have dementia, according to estimates from the World Health Organization?",
    "What is the estimated global economic impact of Alzheimer's disease by 2030?",
    "What are some key references mentioned in this article, and what do they relate to in terms of Alzheimer's disease research?",
    "What is the relationship between the category of body part (e.g., nose, finger, etc.) and the score values in this table?",
    "What was the purpose of the Alzheimer's disease cooperative study mentioned in the text?",
    "What is the current estimated number of people living with Alzheimer's disease worldwide, according to the World Alzheimer Report 2018?",
    "What type of participants were included in the study, and what characteristics did they have in terms of their neuropathological diagnoses?",
    "Does the study by Dronse and colleagues (2017) suggest that there are distinct patterns of tau pathology, amyloid-β burden, and neuronal dysfunction in different clinical variants of Alzheimer's disease?\"",
    "How do the diagnostic guidelines for Alzheimer's disease differ between early-onset and late-onset Alzheimer's disease, as recommended by the National Institute on Aging-Alzheimer's Association workgroups?\"",
    "What is the relationship between tau PET patterns and clinical/neuroanatomical variability in Alzheimer's disease, as observed by N, Baker SL, et al. (2016)?",
    "What percentage increase was there in the association between SA βL and cognitive deficits when compared to SUVr?",
    "What is the significance of the Three-City-Alienor cohort mentioned in this text?",
    "What is the relationship between amyloid deposition, hypometabolism, and longitudinal cognitive decline in Alzheimer's disease, as described by Landau et al. (2012)?",
    "What are the underlying neurodegenerative mechanisms that neuroimaging studies have identified as being targeted by Alzheimer's disease progression?",
    "",
    "What is the limitation of amyloid pathology in estimating the lifetime risk for developing dementia in Alzheimer's Disease?",
    "Who contributed to the design and analysis of the study, according to the author contribution statement?",
    "What are the recommended diagnostic guidelines for Alzheimer's disease according to the National Institute on Aging-Alzheimer's Association workgroups?",
    "",
    "",
    "\"What type of brain imaging technique was used to predict the diagnosis of dementia in this study?\"",
    "What is the estimated number of new dementia cases anticipated every year, according to the World Health Organization?",
    "What was the primary goal of the IDEAS study? ",
    "\"Who is responsible for conceiving and designing the ADNI study?\"",
    "What is the key finding regarding the performance of the proposed method in terms of classification accuracy?",
    "What type of license does the article publication follow?",
    "What are the recommendations made by the International Working Group regarding Alzheimer's disease, as stated in their publication in Lancet Neurol. 2021;20(6):484-496?",
    "What are the diagnostic guidelines for Alzheimer's disease recommended by the National Institute on Aging-Alzheimer's Association workgroups?",
    "Does the amyloid burden, as assessed by tau-positron emission tomography (PET), correlate with neuropathology findings in Alzheimer's disease?",
    "What are the common neuropsychiatric disturbances observed in individuals with mild cognitive impairment?",
    "What is the main focus of each study mentioned in this list?\"",
    "What is the primary focus of the studies listed in this section, and what common thread or characteristic do they share?",
    "What were the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease?",
    "What are the research diagnostic criteria for Alzheimer's disease according to the International Working Group-2 (IWG-2) guidelines?",
    "What role does positron emission tomography (PET) imaging play in the diagnosis and research of Alzheimer's disease, according to this article?",
    "Does the thickness of temporal and parietal cortex relate to the risk of developing dementia in individuals with subjective cognitive decline?",
    "Who are the corresponding authors of this research article?",
    "What limitations does the study identify that need to be addressed in future research on EEG-based AD detection approaches?",
    "What is the purpose of the Addenbrookes's Cognitive Examination in patients with Alzheimer's disease and frontotemporal dementia?",
    "What were the key points that participants were expected to understand before giving informed consent for the PET scan session?",
    "Does the study \"subtypes of Alzheimer's disease based on patterns of brain atrophy\" identify distinct clinical characteristics for each neuropathologically-defined subtype of Alzheimer's disease?",
    "What are the common indicators used in AD research to assess neuronal injury, synaptic dysfunction, and the degree of neurodegeneration?",
    "What was the primary aim of this study in investigating tau pathology and rCBF associations in patients with Alzheimer's disease?",
    "What is the purpose of providing information about Creative Commons licence in this article?",
    "What is the purpose of the Creative Commons licence mentioned at the beginning of the article?\"",
    "What are the implications of using plasma P-tau181 and 231 as diagnostic biomarkers in predicting future cognitive decline?\"",
    "Does the study suggest that disclosing amyloid status to cognitively normal research participants with subjective cognitive decline has any long-term impacts on their symptoms of anxiety, depression, or test-related distress?",
    "\"What is the purpose of referencing the Creative Commons licence in this article?\"",
    "What is the primary focus of the Raskin et al. article in Current Alzheimer Research (2015)?",
    "What is the relationship between Lewy bodies, vascular risk factors, and the development of psychosis in Alzheimer's disease?",
    "What is the estimated global prevalence of Alzheimer's disease by 2050?",
    "What was the average age of the individuals in the study sample?",
    "\"What are the risk factors for behavioral abnormalities in mild cognitive impairment and mild Alzheimer's disease, according to Apostolova et al.'s 2014 study?\"",
    "What is the significance of studying biomarkers in preclinical stages of Alzheimer's disease, as explored in the listed research papers?",
    "Can the CNN-EL approach help predict the conversion of mild cognitive impairment to Alzheimer's disease?",
    "What is the purpose of the A/T/N classification scheme for Alzheimer disease biomarkers discussed in reference 11?\"",
    "What was the expected relationship between cortical amyloid burden, cognitive function, and brain atrophy according to the study's hypothesis?",
    "What is the purpose of mapping CSF biomarker profiles onto NIA–AA guidelines for Alzheimer's disease, as described in reference 54?",
    "What are the possible explanations for the associations found between LAD, AF, and AD pathologies?",
    "\"What organizations or institutions provided funding for this research study?\"",
    "Does the study mentioned in reference 53 suggest any specific cut points for brain aging and Alzheimer's disease, and if so, what are they?",
    "How do the age at onset and disease severity relate to each other in Lewy body variant and Alzheimer's disease, as suggested by Ho GJ et al.?",
    "What are the key recommendations made by the National Institute on Aging-Alzheimer's Association workgroups regarding the diagnosis of mild cognitive impairment due to Alzheimer's disease?",
    "What is the main focus of the Chinese guideline for diagnosing and treating Alzheimer's dementia, as mentioned in reference number 5?",
    "What is the main finding or discovery reported by M. Stazi et al. in their 2021 study?",
    "What were the primary results of the AMBAR Study, a randomized controlled clinical trial of plasma exchange with albumin replacement for Alzheimer's disease?\"",
    "\"What organizations and funding sources supported the research that led to this article?\"",
    "What are some of the investigative procedures used to predict the progression of Alzheimer's disease and improve prognosis?",
    "What were the criteria used to determine eligibility for participation in this study?",
    "What is the key finding that correlates with cognitive status in Alzheimer's disease according to Giannakopoulos et al. (2003)?",
    "What was the purpose of the open-label pilot study conducted by Chow et al. (2013) using fluorodeoxyglucose positron emission tomography in semantic dementia patients treated with memantine?\"",
    "",
    "What was the mean F1-score achieved by the model for FC combined with ApoE4 genotype in predicting whether MMSE score would decrease after 1 year for amyloid-positive individuals?",
    "\"What does the 2021 Alzheimer's Association Report highlight about Alzheimer's disease?\"\"",
    "Did the authors receive any funding for their research, and if so, what was the source of this funding?",
    "What was the characteristic of excessive tau accumulation that distinguished early-onset Alzheimer's disease from other forms of the disease, as reported in the study by Cho et al.?",
    "What is the purpose and scope of the report referred to as \"A report of the amyloid imaging task force, the society of nuclear medicine and molecular imaging, and the Alzheimer's association\"?",
    "What are the typical early-stage symptoms experienced by patients with Alzheimer's disease?",
    "What is the significance of amyloid positivity in relation to clinical progression in mild cognitive impairment, according to Yoon et al. (2019)?",
    "Which organization(s) provided grant support for this study, and what was the nature of these funds?",
    "What institutions were involved in the research described in this article?",
    "\"What is the purpose of including a link to the Creative Commons licence in this article, and what conditions does it specify for using or sharing the content?\"",
    "\"What percentage of patients with mild cognitive impairment progress to Alzheimer's disease each year according to epidemiological studies?\"",
    "What is the correlation between neurofibrillary tangles and the duration and severity of Alzheimer's disease, as described in Arriagada et al. (1992)?",
    "What is the significance of asymmetric caudate hypometabolism observed in patients with semantic dementia and behavioral symptoms, as described in the study by Schwarz et al.?",
    "What is the significance of the age-related distribution of neuropathologic changes in the cerebral cortex, as described in reference #4?",
    "What are the criteria used to diagnose Alzheimer's disease, as described by the International Working Group-2 (IWG-2)?",
    "What is the main objective of the machine learning approach discussed in the 2015 Frontiers in Neurology study \"Alzheimer's disease: a machine learning approach\"?",
    "",
    "\"",
    "What is the significance of mixed pathology in terms of medial temporal lobe atrophy in Alzheimer's disease, as reported by de Flores et al (2020)?",
    "What is the influence of age, disease onset, and ApoE4 on visual medial temporal lobe atrophy cut-offs in Alzheimer's disease?",
    "'What is the significance of the various cognitive and functional scales listed (e.g., ADCS-ADL, BADL, IADL, MMSE, ACE, ADAScog, CDR, GDS) in the context of Alzheimer's Disease research?'",
    "What is the significance of cerebrovascular disease in patients with amnestic mild cognitive impairment and Alzheimer's disease, as mentioned in reference number 23?",
    "\"What are the diagnostic guidelines recommended by the National Institute on Aging-Alzheimer's Association workgroups for Alzheimer's disease?\"",
    "What are the main findings of Melrose et al.'s (2009) FDG-PET study regarding naming and fluency deficits in Alzheimer's disease?",
    "\"What percentage of all causes of dementia are attributed to Alzheimer's disease (AD) according to Kanekar and Poot 2014?\"",
    "\"What is the specific biomarker criteria used to support the diagnosis of MCI/AD in this study?\"",
    "What organizations contributed to the funding of the Alzheimer's Disease Neuroimaging Initiative (ADNI)?",
    "What are the neuropathological findings associated with psychiatric symptoms in Alzheimer's disease?",
    "What role do PLAU, HFE, APP, and BLMH genes play in affecting brain connectivity patterns in Alzheimer's disease?",
    "\"What organizations contributed to the funding of the Alzheimer's Disease Neuroimaging Initiative (ADNI) project?\"",
    "What is the main clinical application of Aβ PET imaging according to the text?\"",
    "\"",
    "What is the diagnostic criteria for the SCIENCe cohort?",
    "What were the results from the Australian imaging, biomarkers, and lifestyle study of ageing regarding predicting Alzheimer disease with beta-amyloid imaging?",
    "\"What is the relationship between childhood-onset epilepsy and amyloid burden decades later, as reported in study #34?\"",
    "What was the area under the curve (AUC) for the diagnosis panel in this study?",
    "What were the imaging biomarkers compared in the study by Mizumura et al. (2015)?",
    "\"What is the affiliation of the corresponding author, Bin Hu?\"",
    "Who provided written informed consent to participate in the study and for the publication of any potentially identifiable images or data included in this article?",
    "What is the focus of Wisse's research studies in Alzheimer's disease and related neurodegenerative disorders?",
    "What were the main findings regarding cognition in Alzheimer's disease mentioned in these scientific articles?",
    "What is the significance of using the real-time quaking-induced conversion assay at the prodromal MCI stage of dementia with Lewy bodies?\"",
    "Did the authors receive any financial support for their research, authorship, or publication of this article?",
    "What was the main focus of the research framework discussed in references 12 and 13?",
    "What were the primary funding sources for this project?",
    "Does the study suggest that hypoperfusion is an early event associated with the build-up of Aβ in the preclinical phase of AD?",
    "What is the significance of CSF biomarkers in determining plaque and tangle burden in definite Alzheimer's disease, as described in reference 24?",
    "\"What were the inclusion and exclusion criteria for patients in the AMBAR trial?\"",
    "What is the significance of the year 2004 in the context of Alzheimer's disease research, according to Klunk et al.'s study?\"",
    "What is the significance of the cerebrospinal fluid tau/β-amyloid42 ratio in predicting cognitive decline in older adults, as reported by Fagan AM et al. in 2007?",
    "\"What is the primary cognitive impairment observed in patients 10-13 based on the text?\"",
    "What was the accuracy rate for predicting cognitive status after one year in amyloid-positive individuals according to the proposed models?",
    "What is the significance of the four prospective cohorts used in the study by Karikari et al. (2020) to evaluate the diagnostic performance and predictive modeling of blood phosphorylated tau 181 as a biomarker for Alzheimer's Disease?",
    "What is the clinical utility of FDG-PET for diagnosing MCI, according to the EANM-EAN Task Force's 2018 study?",
    "What is the significance of tau accumulation as a biomarker for monitoring disease progression in Alzheimer's disease, according to post-mortem studies and recent research?",
    "What were the funding sources for this study, and did any of the authors receive individual grants or stipends? ",
    "What is the significance of the Hisayama study in Alzheimer's disease research?",
    "What is the significance of combining 11C PiB imaging with structural MRI in the diagnosis of Alzheimer's disease and amnestic MCI?",
    "\"What is the typical demographic profile of the patients with AD included in this study?\"",
    "How were the cognitively normal individuals verified and what criteria did they have to meet?",
    "What is the significance of using positron emission tomography in differentiating Alzheimer's disease from other neurodegenerative disorders, as mentioned in the reference \"JAMA Neurol 2020; 77: 955\"?",
    "What types of cognitive decline were hypothesized to be related to neurodegeneration in individuals with Alzheimer's disease-related psychoses?",
    "What is the main goal of the NIA-AA research framework mentioned in reference 9?",
    "Does the NINCDS-ADRDA criteria include a specific FDG-PET pattern as a marker for Alzheimer's disease in the absence of Aβ deposits?",
    "What was the prevalence of dementia subtypes in Medicare fee-for-service beneficiaries from 2011 to 2013, according to SF and Ling SM's study?",
    "What were the distinct PET retention patterns found in early-onset and late-onset Alzheimer's disease patients?",
    "\"What types of brain regions were affected by hypometabolism in amyloid-negative cases with significant precuneus, posterior cingulate and temporal-parietal (PCTP) hypometabolism, as reported in Table 5?\"",
    "What statistical methods and software were used to analyze the data in this study?\"",
    "What is the significance of the APP E665D genetic change in this case of early-onset Alzheimer's disease?",
    "Is all of the custom code used in the study publicly available?",
    "What were the longitudinal changes in tau PET imaging found to be related to hypometabolism in prodromal and Alzheimer's disease dementia?",
    "What is the primary use of amyloid imaging biomarkers in Alzheimer's disease research, according to the text?",
    "What was the primary focus of the longitudinal study conducted by Hanseeuw BJ, Betensky RA, Jacobs HIL, Schultz AP, Sepulcre J, Becker JA, et al. in 2019?",
    "What was the clinical impact of 18F-FDG-PET among memory clinic patients with uncertain diagnosis according to Perini et al.'s 2020 study?",
    "What are the potential cost-saving benefits of using automated EEG systems for detecting Alzheimer's disease?\"",
    "What was the purpose of this study, and what type of brain changes did researchers aim to detect in Alzheimer's disease patients treated with plasma exchange with albumin replacement?",
    "What is the relationship between loss of white matter integrity and tau accumulation in Alzheimer's disease, as described in this study?",
    "What is the typical timeframe for cognitive decline and dementia development after the onset of affective disorders, based on the studies mentioned in this text?",
    "What was the study published in Lancet Neurol. 2011;10(5):424–35 about, and what were its findings regarding cerebral amyloid-β PET with florbetaben (18F)?",
    "What are some common signs or biomarkers that can form before noticeable impairment occurs in Alzheimer's Disease?",
    "What is the key difference in anxiety symptoms between dementia with Lewy bodies and Alzheimer's disease, according to Segers et al.?",
    "Does the ABIDE project study suggest that amyloid PET scans can change patient treatment and diagnosis in an unselected memory clinic cohort?",
    "What is the title of the Radiographics article published in 2014 that discusses patterns of altered FDG metabolism in brain PET imaging for suspected dementia?",
    "What is the purpose of this study among World Trade Center (WTC) responders?",
    "Does the timing of amyloid deposition in AD begin at a very preclinical stage or is it preceded by cognitive impairment?",
    "What was the main focus of the paper published in Journal of Neurology (2022) volume 269, pages 4440-4451?",
    "What are the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease? ",
    "What was the study finding regarding the association between symptoms of apathy and progression from mild cognitive impairment to Alzheimer's disease in non-depressed subjects?",
    "What was the time period during which the anonymized scans from patients with probable DLB were collected?",
    "What is the significance of depressive symptoms in mild cognitive impairment patients in predicting atrophy in Alzheimer's disease-related regions?",
    "What is the purpose of ongoing studies investigating the etiology of early onset neurocognitive dysfunction in World Trade Center responders?\"",
    "What is the primary focus of the studies cited in this chunk, and how do they relate to dementia of Alzheimer's type?",
    "What is the relationship between tau, Abeta, and cortical thickness with cognition in Alzheimer's disease as described in these studies?",
    "Is the age-dependent amyloid deposition mentioned in the first study (Park DC, et al., 2020) a unique characteristic of cognitively normal adults during the adult life span?",
    "What was the significance of the P-value in the comparison between Alzheimer's disease and control groups, as indicated by the MMSE scores?",
    "What were the specific verbal memory and language fluency tests that showed improved scores in mild AD patients treated with PE? ",
    "What percentage of participants had cortical and striatal uptake on amyloid PET imaging?",
    "\"What criteria were used to establish the diagnosis of SCD and MCI/AD in this study?\"",
    "\"What is the significance of [18F]GTP1 as a radioligand for detecting neurofibrillary tangle tau pathology in Alzheimer's disease, according to Sanabria Bohórquez S et al. (2019)?\"",
    "\"What organizations contributed to the funding of the Alzheimer's Disease Neuroimaging Initiative (ADNI)?",
    "What were the biomarkers that combined cytokines and MRI measures used to predict disease progression in mild cognitive impairment conversion to Alzheimer's disease?",
    "What is the relationship between β-amyloid and structural network topology in decedents without dementia, as studied by Jonkman et al in 2020?",
    "What is the primary goal of the Alzheimer's Disease Neuroimaging Initiative (ADNI) database, as mentioned in the text?",
    "What is the relationship between prefrontal hypometabolism and longitudinal amyloid accumulation in remote brain regions in Alzheimer's disease, according to Klupp et al.'s 2015 study?",
    "What are the key cognitive functions that are affected by dementia, according to the World Health Organization definition?",
    "What is the primary mechanism by which education reduces cognitive dysfunction in individuals with Alzheimer's disease, according to the study mentioned in reference 52?",
    "What was the first tau PET tracer approved for use in diagnosing Alzheimer's disease, according to Hartel H (2020)?",
    "What were the main findings regarding brain glucose metabolism and its relation to early diagnosis of Alzheimer's disease in Mosconi L.'s study (2005)?",
    "",
    "What was the main technique used to improve Alzheimer's disease diagnosis in the 2011 study by Trambaiolli et al.?",
    "What are some possible reasons for the selective vulnerability of certain brain areas, such as the amygdala, to β-amyloid, tau, orα-synuclein deposits, which could contribute to the development of NPS decades before neurological changes occur?",
    "",
    "\"What were the demographic characteristics of the patients included in this study?\"",
    "What was the estimated effective dose per megabecquerel (mSv/MBq) for males and females using the radiotracer [18F] JNJ-64326067?",
    "What is the primary method used to diagnose and monitor the progression of Alzheimer's disease in the Tripoliti et al. (2011) study?",
    "What are some of the challenges or problems that researchers face when trying to translate bench research into clinical trials for Alzheimer's disease, according to Krstic and Knuesel (2013)?",
    "Which study compared multiple tau-PET measures to define imaging biomarker cut points for brain aging and Alzheimer's disease?",
    "",
    "What is the relationship between CSF p-tau and [18F]flortaucipir PET with multiple cognitive domains and regional atrophy in terms of disease severity?",
    "What is the main topic or guideline discussed in the series of papers (2011) published by the National Institute on Aging-Alzheimer's Association workgroups? ",
    "What was the outcome of the conversion of amyloid-positive and negative MCI to AD over a period of 3 years, as observed in an 11C-PIB PET study?",
    "What are the key findings from the SCIENCe project regarding the relationship between amyloid PET and cognitive decline in cognitively normal individuals?",
    "What was the key finding from the study that distinguished Alzheimer's disease from healthy aging using functional MRI?",
    "What is the potential significance of ATN plasma biomarkers for identifying pathological features of Alzheimer's Disease, according to the abstract?",
    "What is the primary cause of cognitive impairment in the patients described in this text?",
    "What was the C-index value achieved by the combined model for predicting conversion risk from MCI to AD?",
    "",
    "What are the inclusion criteria for Cohort E, which covers other non-AD dementias and neurodegenerative disorders?",
    "What are the key differences in brain connectivity patterns between normal aging and Alzheimer's disease, as revealed by a structural k-core network analysis?",
    "What is the association found between widespread brain tau and aging according to Low et al.'s study?\"",
    "Does the combination of glucose metabolism, gray matter structure, and memory decline play a significant role in subjective memory impairment?",
    "\"What is the estimated number of AD patients in the USA by 2050, according to the text?\"",
    "\"What is the source of funding for HZ's conflict of interest declarations?\"",
    "How do physicians caring for older patients with epilepsy differentiate between cognitive symptoms caused by seizures or drug side effects versus underlying neurodegenerative diseases like Alzheimer's disease?",
    "What percentage of companies/products assessed had no publications meeting the inclusion criteria?",
    "What factors contribute to the negative results seen in previous studies on multidomain interventions for preventing dementia, according to this text?",
    "\"What is the purpose of the Alzheimer's Disease Neuroimaging Initiative (ADNI) database, according to this publication?\"",
    "What are some examples of autoimmune dementia-related antibodies that have been discovered in research?",
    "What type of ethical approval and informed consent procedures were followed in this study, as described in the Ethical Statement section?\"",
    "What is the Clinical Dementia Rating (CDR) scale used to assess in studies of Alzheimer's disease?",
    "What is the specific role of hippocampal alpha-synuclein in dementia with Lewy bodies, according to Adamowicz et al.'s 2017 study?",
    "What was the main goal of the Alzheimer's disease neuroimaging initiative (ADNI) project?",
    "What is the association between white matter hyperintensities and Alzheimer's disease, according to the studies cited in this chunk of text?",
    "What radiomic biomarkers were identified by Zhou H, Jiang J, Lu J, Wang M, Zhang H, and Zuo C as predicting the development of mild cognitive impairment progression to Alzheimer's disease?",
    "\"Do the accuracy and prognostic value of tau positron emission tomography differ from those of amyloid positron emission tomography in preclinical and prodromal Alzheimer disease, as reported by Ossenkoppele et al. (2021)?\"",
    "What were the diagnostic criteria used to confirm MCI in the study participants?",
    "What is the relationship between brain atrophy and cognitive complaints in older adults with subjective memory impairment?",
    "Does the study investigate any correlations between brain atrophy, cognitive scores, APOE genotype, and CSF biomarkers in Alzheimer's disease patients?",
    "\"What was the duration between cognitive evaluations after patient admission to the center?\"",
    "What is the main finding of the study published in Acta Neuropathologica (2022) regarding cerebral amyloid-β accumulation?",
    "What is the purpose of the ADNI database and who contributed to its design and implementation?",
    "What is the significance of the correlations between regional SUVR and MMSE score in this study?",
    "Does the BioFINDER study and the Alzheimer’s Disease Neuroimaging Initiative (ADNI) suggest that higher levels of plasma NfL predict faster cognitive decline in people with subtle cognitive changes or MCI?",
    "What is the purpose of thanking the Alzheimer’s Disease Neuroimaging Initiative (ADNI) for providing data in this research article?",
    "What is the purpose of the first-in-human study referenced in this list of research articles?\"",
    "What is the significance of striatal amyloid plaque density in predicting Braak neurofibrillary stage and clinicopathological Alzheimer's disease, as suggested by Beach et al.'s study? ",
    "What is the relationship between mid-life vascular risk factors and amyloid deposition in late life?",
    "What was the purpose of the \"Inventory to assess activities of daily living\" developed by Galasko et al. in 1997, as mentioned in reference #14?",
    "What was the main finding suggested by recent work regarding the cause of sporadic-Alzheimer's disease?",
    "What criteria were used to diagnose Alzheimer's disease in this study?",
    "What was the relationship found between amyloid deposits and blood vessels in the cerebral white matter of Alzheimer's disease brains?",
    "\"What were the primary cognitive impairments observed in this patient with a diagnosis of Alzheimer's disease?\"",
    "What are the benefits of using Positron Emission Tomography (PET) imaging technique in evaluating Alzheimer's disease (AD), according to this review?",
    "What is the specific neuropsychological profile mentioned in the reference \"with a distinct neuropsychological profile. J Alzheimers Dis. 2012;30(1):101–8\"?",
    "What types of machine learning techniques were used in the hybrid gene selection pipeline to classify Alzheimer's disease?",
    "What is the main finding or conclusion presented in reference number 40 regarding cerebral amyloid angiopathy?",
    "What is the conclusion drawn by Cummings et al. regarding the clinical benefit of aducanumab in reducing amyloid levels?",
    "What is the primary topic of the report \"World Alzheimer report 2018\" discussed in reference number 2?",
    "What types of biomarkers were studied in these papers for Alzheimer's Disease diagnosis and progression prediction?",
    "What is the purpose of the Magnetic Resonance Imaging (MRI) in the Alzheimer's Disease Neuroimaging Initiative 2 mentioned in reference 32?",
    "What is the significance of assessing Alzheimer's Disease imaging biomarkers in World Trade Center responders with cognitive impairment?",
    "What are the key imaging biomarkers used to assess the likelihood that clinical symptoms are due to AD, according to the NIA-AA and IWG guidelines?",
    "What is the significance of providing highly congruent results in score analysis, according to the text?",
    "What are the key biomarkers used to predict the progression from mild cognitive impairment (MCI) to Alzheimer's disease (AD), according to the study mentioned in reference 7?\"",
    "What is the hypothesized order of events in the development of Alzheimer's Disease, according to current understanding?",
    "What were the primary cognitive impairments observed in this patient's neuropsychological testing, and how did they progress over time?",
    "What was the number of target peptides and identified target proteins analyzed in this study to develop a serum-based diagnostic panel for Alzheimer's disease?",
    "Does the emergence of contradictory evidence suggest a reevaluation of the traditional understanding of Alzheimer's Disease progression?",
    "What were the primary outcomes or findings of the 2013 study by Mathis CA and colleagues on in vivo assessment of amyloid-beta deposition in non-demented very elderly subjects?\"",
    "Can the plasma Aβ42/40 ratio, ApoE proteotype, and age accurately identify brain amyloid status in all individuals, as claimed by West et al. (2021)?",
    "What is the primary topic of discussion in this section of text, and how does it relate to Alzheimer's Disease research?",
    "What was the purpose of the visual and semiquantitative analysis conducted by Jimenez-Bonilla et al. (2016) on amyloid imaging with 11C-PIB in patients with cognitive impairment?",
    "What is the significance of the studies mentioned in this section regarding Alzheimer's disease diagnosis and prognosis?",
    "What is the typical time period between the onset of amyloid deposition and the development of clinical manifestations of dementia or MCI in Alzheimer's disease patients?",
    "What is the relationship between BOLD amplitude and different stages of cognitive decline, as shown in this table?",
    "What is the relationship between plasma amyloid beta and tau levels and post-stroke cognitive impairment, according to the study by Chi et al. (2019)?",
    "What was the main finding regarding gene expression in P301L transgenic mice and human Alzheimer's disease, as reported in Proc Natl Acad Sci U S A in 2018?",
    "Does the study by Tang et al. (2018) suggest a correlation between plasma beta-amyloids and cognitive impairment in patients with vascular cognitive impairment?",
    "\"What was the source of grant support for Van der Flier?\"",
    "What is the main purpose of the study comparing 18F-flortaucipir PET to autopsy in Alzheimer's disease and other neurodegenerative diseases?",
    "What are the logical criteria for diagnosing mild cognitive impairment, according to the Alzheimer's Disease Neuroimaging Initiative? ",
    "What were the sources of biomarkers in this study's evaluation of brain pathology and cognitive change in Alzheimer's disease patients?",
    "What were the primary funding sources for this research project?",
    "What is the relationship between beta-amyloid and tauopathy in Alzheimer's disease, according to the studies cited?\"",
    "How do the triple transgenic mouse models described in Saul et al. (2013) compare to other Alzheimer's disease models in terms of accelerated tau pathology and synaptic/neuronal loss?",
    "Does the study suggest that relying on semi-quantitative Z-score analysis facilitates qualitative adjudication of Aβ positivity in patients with possible AD?",
    "What is the predicted increase in people living with dementia by 2050, according to recent forecasts?",
    "What is the significance of considering images as more than just pictures in the context of Alzheimer's disease research?",
    "What are the six cognitive domains evaluated by the Addenbrooke's Cognitive Examination (ACE)?",
    "\"Who provided the precursor for the synthesis of [18F]-APN-1607 in this study?\"",
    "What is the primary purpose of this study in investigating Alzheimer's disease, according to the abstract?",
    "Does the provided list of references primarily focus on Alzheimer's disease or does it cover a broader range of topics related to brain function and neuroimaging?",
    "What are some potential implications for using criterion 2 in considering older patients with epilepsy and cognitive impairment for amyloid PET imaging?",
    "\"What is the correlation between amyloid burden and cognitive impairment in Alzheimer's disease, according to this study?\"",
    "What are the three studies mentioned in this chunk that have been published in peer-reviewed journals and are related to Alzheimer's disease research?",
    "",
    "What role has tau imaging been suggested to play in staging and assessing the prognosis of Alzheimer's disease, according to the research mentioned?\"",
    "Do the authors of this study find a correlation between in-vivo MRI metrics and Braak neurofibrillary tangle staging?",
    "What diagnostic criteria were used to determine the diagnosis of AD or MCI in this study?",
    "What was the objective of the IDEAS study in identifying subjects with cognitive decline and non-lesional epilepsy, according to the abstract?",
    "What was notable about Case 1 that made it challenging to interpret the results of a diagnostic test?",
    "What was the main focus of Morris et al.'s 2016 systematic review and meta-analysis in Eur J Nucl Med Mol Imaging?",
    "\"What are the sources of funding and support for each author mentioned in the study?\"",
    "What do studies 48-52 suggest about semantic memory impairment in Alzheimer's disease?\"",
    "What is the effectiveness of using 18F-FDG PET in evaluating dementia, according to a review of recent literature published in the Journal of Nuclear Medicine?",
    "Does the study compare the distribution and intensity of off-target binding between patients with AD, MCI-AD, and healthy controls?",
    "What is the association between cerebral amyloid angiopathy and cognitive outcomes in community-based older persons?",
    "What types of datasets were included in the study, and from which sources did they originate?",
    "\"Who is the corresponding author of this research article and what is their email address?\"",
    "What was the role of 18F-florbetapir Amyloid PET Imaging in diagnosing patients with multiple sclerosis and dementia?",
    "What is the significance of the Geriatric Depression Scale (GDS) in this study, and what are the average scores reported?\"",
    "What is the biochemical pathway of neurofibrillary degeneration in aging and Alzheimer's disease according to Delacourte et al. (1999)?",
    "What brain regions are typically affected by increased amyloid uptake in Alzheimer's disease patients, according to PET scans? ",
    "What is the relationship between demyelination levels in white matter and clinical progression in early stages of Alzheimer's disease?",
    "What were the four distinct trajectories of tau deposition identified in Alzheimer's disease, as described in reference 43?\"",
    "",
    "What is the name of the tablet-based drawing task mentioned as a diagnostic tool for discriminating patients with early-stage Alzheimer's disease from healthy individuals?",
    "",
    "What cognitive and psychosocial outcomes are being referred to in this list of research studies?",
    "What are the three binary categories used by Jack et al. to classify patients with cognitive impairment in their novel system?",
    "What are the two amyloid-β isoforms that are characterized as causing brain infiltration and Aβ deposition in AD, according to the new research ATN framework?",
    "\"What is the nature of the material that is available to authorized users, according to this publication?\"",
    "What is the association between tau protein levels and brain atrophy severity in both stroke patients and normal controls?",
    "What is the primary focus of the papers listed in this chunk of text?",
    "Does the study \"Impaired Aβ clearance: a potential link between atherosclerosis and Alzheimer's disease\" suggest that there is a direct causal relationship between the two conditions?",
    "How were the CN cases selected for the test set in this study to ensure a balanced representation from both ADNI and EDLB sources?",
    "\"What do the studies mentioned in this chunk suggest is the best predictor of cognitive decline in Alzheimer's disease?\"",
    "Who provided funding for the ADNI clinical sites in Canada?",
    "What is the role of glial and neuronal tau pathology in tauopathies, as characterized by Ferrer et al. (2014)?",
    "What is the proposed hypothesis regarding the initiating factor in sporadic Alzheimer's disease according to Arnsten et al.?",
    "What is the potential neuropathological etiology of cognitive decline in WTC responders with neurocognitive dysfunction?",
    "What criteria did the three cognitive neurologists use to determine the likelihood of underlying AD neuropathology in the subjects studied?\"",
    "What is the main cause of dementia, according to this text?",
    "What type of deep learning architectures were used by Ortiz et al. (2016) for the early diagnosis of Alzheimer's disease?",
    "What are the main causes of EEG slowing and dementia, according to the research mentioned in this section?",
    "What type of plots were used to depict the median in this study?",
    "What are the key guidelines for neuropathologic assessment of Alzheimer's Disease mentioned in this text?",
    "What neuroimaging biomarkers were found to be effective in monitoring the progression of amnestic mild cognitive impairment?\"",
    "Does MRI-based demyelination have a significant impact on the clinical progression of Alzheimer's disease participants, particularly those in preclinical and prodromal stages?",
    "What was the main finding of this study regarding the relationship between tau pathology, rCBF, and cognitive deficits in Alzheimer's disease?",
    "\"What is the purpose of early diagnosis of mild cognitive impairment (MCI) supported by emerging digital technologies, as discussed in Sabbagh et al.'s 2020 study?\"",
    "What was the rationale behind excluding patients without amyloid pathology from the study?",
    "What are the preclinical stages of Alzheimer's disease, according to the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease?",
    "What were the recommendations made by the National Institute on Aging-Alzheimer's Association workgroups regarding diagnostic guidelines for Alzheimer's disease in the preclinical stages?",
    "Does the study \"hyperperfusion in cognitively normal APOEe4 allele carriers in mid-life: analysis of ASL pilot data from the PREVENT-Dementia cohort\" suggest that APOEe4 allele carriers have an increased risk of developing Alzheimer's disease?",
    "What are some common scales or assessments used to evaluate dementia in this list of references?",
    "What is the role of glycogen synthase kinase-3 (GSK-3) in Alzheimer's disease, according to the text?",
    "What are the proposed \"appropriate use criteria\" for amyloid PET imaging?\"",
    "Who are the researchers involved in the Alzheimer’s Disease Neuroimaging Initiative?",
    "What is the specific brain region or regions that have been found to be associated with naming difficulty in Alzheimer's disease, according to the cited studies?",
    "What percentage of patients with Multiple Sclerosis experience cognitive dysfunction, according to the text?",
    "What is the most common clinical information reported in the study, as inferred from the \"Clinical information\" column in Table 2?",
    "What is the significance of ApoE2 in Alzheimer's disease, according to Reiman et al.'s 2020 study?",
    "What are the implications of striatal and cortical amyloid deposition on cognitive function in Alzheimer's disease?",
    "What are some common biomarkers used to predict progression from mild cognitive impairment to Alzheimer's disease, according to the references provided?",
    "What is the significance of the APOE4 allele in disrupting resting state fMRI connectivity?",
    "What is the primary goal of the study described in this abstract, according to the author's purpose statement?",
    "What is the common feature found in both typical and atypical Alzheimer's disease, according to Rohrer JD et al.'s 2010 study?",
    "",
    "What is the clinical utility of amyloid PET imaging in diagnosing dementia, according to recent studies?",
    "What is the purpose of this study regarding neurovascular coupling in early stage dementia?",
    "\"What is the significance of the increasing incidence of neuro-cognitive and neurobehavioral dysfunction in WTC responders?\"",
    "\"What type of diseases and proteinopathies are prevalent among individuals with APOE4-association, according to the study by Robinson JL et al (2018)?\"",
    "What machine learning framework was developed by Moradi et al. (2015) for predicting Alzheimer's conversion in MCI subjects based on MRI data?",
    "",
    "Does the presence of aphasia in individuals with ADOD necessarily imply that Alzheimer's Disease neuropathology is present?",
    "What is the implication of polygenic risk score for Alzheimer's disease on memory performance and hippocampal volumes in early life, as suggested by Axelrud et al. (2018)?",
    "What percentage of patients with autoimmune etiologies of dementia were initially misdiagnosed with an irreversible neurodegenerative dementia or prion disorder?",
    "What was the diagnosis made for the 75-year-old male patient presented in this case study?",
    "What is the significance of this APP variant (E665D) in relation to progressive cognitive decline and cerebral amyloid angiopathy?",
    "What is the primary method used for Alzheimer's disease classification in the Farooq et al. (2017) study?",
    "What is the correlation between functional connectivity and tau deposition in individuals with normal amyloid beta levels?",
    "What is the relationship between autonomic dysfunction and Alzheimer's disease as described in the paper by Femminella et al.?",
    "",
    "What are the key associations found between [(18)F]flortaucipir tau PET and atrophy across the Alzheimer's disease spectrum according to Timmers et al.?",
    "What types of cognitive tests are used for screening Alzheimer's disease in the study mentioned by Perez-Valero et al.?",
    "What is the purpose of referencing multiple studies with specific page ranges (e.g., 15: 106–152) at the end of this text?",
    "What is the primary focus of the studies cited in this section, and how do they relate to Alzheimer's disease research?",
    "\"What were the inclusion criteria for selecting participants in this study?\"",
    "What are the locations of the research institutions or hospitals involved in Alzheimer's disease research as listed in this text?",
    "What are the associations between cognitive, functional, and FDG-PET measures of decline in Alzheimer's disease and mild cognitive impairment, according to the study by Landau et al.?\"",
    "What were the main findings regarding the relationships between tau PET binding, amyloid burden, clinical diagnosis, age, and cognition in these studies?",
    "What is the key predictor of incident Alzheimer's disease identified in a community-based study? ",
    "What are the implications of using automated methodologies for quantitative neuropathology in large-scale cohorts, as discussed in Walker et al.'s 2017 study?",
    "What is the significance of using Amyloid PET imaging in MS patients with dementia when distinguishing between dementia due to MS alone and coexisting neurodegenerative diseases?",
    "Does the presence of white matter hyperintensities predict longitudinal cognitive change in clinically normal older adults independently of amyloid status?",
    "What is the sensitivity and specificity of [18F]Flortaucipir in visualizing and quantifying tau pathology using PET? ",
    "What is the significance of the Clinical Dementia Rating Scale (CDR) in assessing dementia severity, as mentioned in references 22, 23, and 24?\"",
    "What were the exclusion criteria for participating in this study?",
    "What is the estimated number of Alzheimer's disease cases in the United States from 2010 to 2050, according to the study by Hebert et al. (2013)?",
    "",
    "What are the diagnostic guidelines for Alzheimer's disease, as recommended by the National Institute on Aging-Alzheimer’s Association workgroups?",
    "What is the estimated prevalence of Alzheimer's disease in the United States from 2010 to 2050, according to Heber t LE, Weuve J, Scherr PA, and Evans DA?\"",
    "What was the gold standard used for diagnosing Alzheimer's disease in this study, and how were patients diagnosed? ",
    "What was the time period during which participants in this study were enrolled?",
    "Is the plasma amyloid assay a reliable pre-screening tool for detecting early-stage Alzheimer's disease, as suggested in Lin et al.'s (2019) study?\"",
    "What is the hypothetical model of dynamic biomarkers for Alzheimer's disease discussed in the article by Jack CR Jr, et al.?",
    "\"What was the size and composition of the primary study cohort?\"",
    "What are the common symptoms of autoimmune encephalopathy/dementia, and how do they differ from those of other causes of dementia?",
    "What are the recommended management strategies for neuropsychiatric symptoms of dementia, according to a multidisciplinary expert panel?",
    "What were the findings of the review of 55 studies on the epidemiology of and risk factors for psychosis of Alzheimer's disease, published from 1990 to 2003?",
    "What was the purpose of the multisite PET study approach validated in Roysse et al.'s 2021 paper?",
    "What is the common theme among the studies cited by these authors (Rice, Rosler, Rub, etc.)?"
  ]
}